{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:28:51Z","timestamp":1793114931793,"version":"4.5.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,5,23]]},"abstract":"<jats:sec id=\"ab-joi230048-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>There are limited data on the outcomes of transcatheter edge-to-edge mitral valve repair for degenerative mitral regurgitation (MR) in a real-world setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-joi230048-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the outcomes of transcatheter mitral valve repair for degenerative MR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-joi230048-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>Cohort study of consecutive patients in the Society of Thoracic Surgeons\/American College of Cardiology Transcatheter Valve Therapies Registry who underwent nonemergent transcatheter mitral valve repair for degenerative MR in the US from 2014 through 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-joi230048-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Transcatheter edge-to-edge mitral valve repair with the MitraClip device (Abbott).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-joi230048-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary end point was MR success, defined as moderate or less residual MR and a mean mitral gradient of less than 10 mm Hg. Clinical outcomes were evaluated based on the degree of residual MR (mild or less MR or moderate MR) and mitral valve gradients (\u22645 mm Hg or &amp;amp;gt;5 to &amp;amp;lt;10 mm Hg).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-joi230048-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 19\u202f088 patients with isolated moderate to severe or severe degenerative MR who underwent transcatheter mitral valve repair were analyzed (median age, 82 years; 48% women; median Society of Thoracic Surgeons predicted risk of mortality with surgical mitral valve repair, 4.6%). MR success was achieved in 88.9% of patients. At 30 days, the incidence of death was 2.7%; stroke, 1.2%; and mitral valve reintervention, 0.97%. MR success compared with an unsuccessful procedure was associated with significantly lower mortality (14.0% vs 26.7%; adjusted hazard ratio, 0.49; 95% CI, 0.42-0.56;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001) and heart failure readmission (8.4% vs 16.9%; adjusted hazard ratio, 0.47; 95% CI, 0.41-0.54;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001) at 1 year. Among patients with MR success, the lowest mortality was observed in patients who had both mild or less residual MR and mean mitral gradients of 5 mm Hg or less compared with those with an unsuccessful procedure (11.4% vs 26.7%; adjusted hazard ratio, 0.40; 95% CI, 0.34-0.47;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-joi230048-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this registry-based study of patients with degenerative MR undergoing transcatheter mitral valve repair, the procedure was safe and resulted in successful repair in 88.9% of patients. The lowest mortality was observed in patients with mild or less residual MR and low mitral gradients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2023.7089","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T11:04:53Z","timestamp":1684839893000},"page":"1778","source":"Crossref","is-referenced-by-count":156,"title":["Transcatheter Mitral Valve Repair for Degenerative Mitral Regurgitation"],"prefix":"10.1001","volume":"329","author":[{"given":"Raj R.","family":"Makkar","sequence":"first","affiliation":[{"name":"Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Chikwe","sequence":"additional","affiliation":[{"name":"Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Chakravarty","sequence":"additional","affiliation":[{"name":"Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiudong","family":"Chen","sequence":"additional","affiliation":[{"name":"Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"O\u2019Gara","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Gillinov","sequence":"additional","affiliation":[{"name":"Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Mack","sequence":"additional","affiliation":[{"name":"Baylor Scott and White Health, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Vekstein","sequence":"additional","affiliation":[{"name":"Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhairya","family":"Patel","sequence":"additional","affiliation":[{"name":"Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Lee","family":"Stebbins","sequence":"additional","affiliation":[{"name":"Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annetine C.","family":"Gelijns","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moody","family":"Makar","sequence":"additional","affiliation":[{"name":"Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Kapadia","sequence":"additional","affiliation":[{"name":"Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreekanth","family":"Vemulapalli","sequence":"additional","affiliation":[{"name":"Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Leon","sequence":"additional","affiliation":[{"name":"Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9540","key":"joi230048r1","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study.","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet"},{"issue":"13","key":"joi230048r2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0195-668X(03)00201-X","article-title":"A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease.","volume":"24","author":"Iung","year":"2003","journal-title":"Eur Heart J"},{"issue":"3","key":"joi230048r3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrcardio.2011.169","article-title":"Treatment and management of mitral regurgitation.","volume":"9","author":"De Bonis","year":"2011","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"joi230048r4","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.athoracsur.2018.03.086","article-title":"Isolated mitral valve surgery: the Society of Thoracic Surgeons Adult Cardiac Surgery Database analysis.","volume":"106","author":"Gammie","year":"2018","journal-title":"Ann Thorac Surg"},{"issue":"18","key":"joi230048r5","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1161\/CIRCULATIONAHA.113.002200","article-title":"Long-term survival of patients undergoing mitral valve repair and replacement: a longitudinal analysis of Medicare fee-for-service beneficiaries.","volume":"127","author":"Vassileva","year":"2013","journal-title":"Circulation"},{"issue":"10","key":"joi230048r6","doi-asserted-by":"publisher","first-page":"II90","DOI":"10.1161\/01.cir.0000089182.44963.bb","article-title":"Outcome of mitral valve repair or replacement: a comparison by propensity score analysis.","volume":"108","author":"Moss","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"joi230048r7","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S0002-8703(96)90182-9","article-title":"Mitral valve repair is superior to valve replacement for the early preservation of cardiac function: relation of ventricular geometry to function.","volume":"131","author":"Ren","year":"1996","journal-title":"Am Heart J"},{"issue":"5","key":"joi230048r8","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1161\/CIRCULATIONAHA.116.023340","article-title":"Twenty-year outcome after mitral repair versus replacement for severe degenerative mitral regurgitation: analysis of a large, prospective, multicenter, international registry.","volume":"135","author":"Lazam","year":"2017","journal-title":"Circulation"},{"issue":"15","key":"joi230048r9","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","article-title":"Percutaneous repair or surgery for mitral regurgitation.","volume":"364","author":"Feldman","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"joi230048r10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jacc.2013.12.062","article-title":"Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study.","volume":"64","author":"Glower","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"joi230048r11","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/ehjci\/jeaa062","article-title":"Conceiving MitraClip as a tool: percutaneous edge-to-edge repair in complex mitral valve anatomies.","volume":"21","author":"Gavazzoni","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"joi230048r12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jcin.2014.07.024","article-title":"Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry.","volume":"8","author":"Attizzani","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"23","key":"joi230048r13","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/j.jacc.2021.07.058","article-title":"Transcatheter mitral valve therapy in the United States: a report from the STS-ACC TVT registry.","volume":"78","author":"Mack","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"joi230048r14","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1016\/j.jacc.2017.09.015","article-title":"Outcomes with transcatheter mitral valve repair in the United States: an STS\/ACC TVT registry report.","volume":"70","author":"Sorajja","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"joi230048r15","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/eurheartj\/ehq331","article-title":"A propensity score-adjusted retrospective comparison of early and mid-term results of mitral valve repair versus replacement in octogenarians.","volume":"32","author":"Chikwe","year":"2011","journal-title":"Eur Heart J"},{"issue":"24","key":"joi230048r16","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure.","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med"},{"issue":"24","key":"joi230048r17","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation.","volume":"379","author":"Obadia","year":"2018","journal-title":"N Engl J Med"},{"key":"joi230048r18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2300213","article-title":"Five-year follow-up after transcatheter repair of secondary mitral regurgitation.","author":"Stone","year":"2023","journal-title":"N Engl J Med"},{"issue":"20","key":"joi230048r19","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1016\/j.jcin.2020.06.053","article-title":"Transcatheter edge-to-edge mitral valve repair with the MitraClip G4 system.","volume":"13","author":"Chakravarty","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"joi230048r21","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/jamacardio.2020.2221","article-title":"Volume-outcome association of mitral valve surgery in the United States.","volume":"5","author":"Badhwar","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"8","key":"joi230048r22","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.jacc.2019.06.052","article-title":"Long-term results of mitral valve repair for regurgitation due to leaflet prolapse.","volume":"74","author":"David","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"joi230048r23","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S0022-5223(98)00450-4","article-title":"Durability of mitral valve repair for degenerative disease.","volume":"116","author":"Gillinov","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"joi230048r24","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.athoracsur.2015.05.068","article-title":"The expanding role of endoscopic robotics in mitral valve surgery: 1257 consecutive procedures.","volume":"100","author":"Murphy","year":"2015","journal-title":"Ann Thorac Surg"},{"issue":"12","key":"joi230048r25","doi-asserted-by":"publisher","first-page":"I1","DOI":"10.1161\/hc37t1.094903","article-title":"Very long-term survival and durability of mitral valve repair for mitral valve prolapse.","volume":"104","author":"Mohty","year":"2001","journal-title":"Circulation"},{"issue":"4","key":"joi230048r26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa2115961","article-title":"Concomitant tricuspid repair in patients with degenerative mitral regurgitation.","volume":"386","author":"Gammie","year":"2022","journal-title":"N Engl J Med"},{"issue":"10124","key":"joi230048r27","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S0140-6736(18)30473-2","article-title":"Outcome and undertreatment of mitral regurgitation: a community cohort study.","volume":"391","author":"Dziadzko","year":"2018","journal-title":"Lancet"},{"issue":"24","key":"joi230048r28","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1016\/j.jcin.2022.09.005","article-title":"Randomized comparison of transcatheter edge-to-edge repair for degenerative mitral regurgitation in prohibitive surgical risk patients.","volume":"15","author":"Lim","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"joi230048r20","author":"Rogers","year":"2022"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2805140\/jama_makkar_2023_oi_230048_1684251834.59422.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T11:04:56Z","timestamp":1684839896000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2805140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":28,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2023,5,23]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.7089","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,23]]}}}